pI: 5.7854 |
Length (AA): 183 |
MW (Da): 19457 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
43 | 182 | 2e5y (A) | 2 | 130 | 18.00 | 0 | 0.82 | 1.00303 | -0.62 |
44 | 181 | 2v7q (H) | 15 | 144 | 31.00 | 0.000000028 | 1 | 1.1653 | -0.69 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | VEG Tachyzoite, ME49 Tachyzoite, ME49 merozoite, ME49 Bradyzoite. | Gregory Hehl AB Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | ME49 Oocyst. | Fritz HM |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Ortholog group members (OG5_127404)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | ArthCp028 | ATP synthase epsilon chain |
Arabidopsis thaliana | AT5G47030 | ATP synthase subunit delta' |
Babesia bovis | BBOV_III004400 | ATP synthase, Delta/Epsilon chain, beta-sandwich domain containing protein |
Brugia malayi | Bm1_57260 | ATP synthase delta chain, mitochondrial precursor, putative |
Candida albicans | CaO19.7678 | ATP synthase delta subunit |
Caenorhabditis elegans | CELE_F58F12.1 | Protein F58F12.1 |
Dictyostelium discoideum | DDB_G0269038 | ATP synthase F1 delta |
Drosophila melanogaster | Dmel_CG2968 | lethal (1) G0230 |
Escherichia coli | b3731 | F1 sector of membrane-bound ATP synthase, epsilon subunit |
Echinococcus granulosus | EgrG_000656000 | 5'partial|ATP synthase subunit delta mitochondrial |
Echinococcus multilocularis | EmuJ_000656000 | ATP synthase subunit delta, mitochondrial |
Homo sapiens | ENSG00000099624 | ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit |
Leishmania braziliensis | LbrM.30.3630 | ATP synthase, epsilon chain, putative |
Leishmania donovani | LdBPK_303660.1 | ATP synthase, epsilon chain, putative |
Leishmania infantum | LinJ.30.3660 | ATP synthase, epsilon chain, putative |
Leishmania major | LmjF.30.3600 | ATP synthase, epsilon chain, putative |
Leishmania mexicana | LmxM.29.3600 | ATP synthase, epsilon chain, putative |
Loa Loa (eye worm) | LOAG_04001 | ATP synthase subunit delta |
Mycobacterium leprae | ML1146 | PROBABLE ATP SYNTHASE EPSILON CHAIN ATPC |
Mus musculus | ENSMUSG00000003072 | ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit |
Mycobacterium tuberculosis | Rv1311 | Probable ATP synthase epsilon chain AtpC |
Mycobacterium ulcerans | MUL_3953 | F0F1 ATP synthase subunit epsilon |
Neospora caninum | NCLIV_046830 | ATP synthase, putative |
Oryza sativa | 4343288 | Os07g0495200 |
Onchocerca volvulus | OVOC9964 | ATP synthase subunit delta, mitochondrial homolog |
Plasmodium berghei | PBANKA_0901400 | ATP synthase subunit delta, mitochondrial, putative |
Plasmodium falciparum | PF3D7_1147700 | ATP synthase subunit delta, mitochondrial, putative |
Plasmodium knowlesi | PKNH_0945600 | ATP synthase subunit delta, mitochondrial, putative |
Plasmodium vivax | PVX_092970 | hypothetical protein, conserved |
Plasmodium yoelii | PY05978 | hypothetical protein |
Saccharomyces cerevisiae | YDL004W | F1F0 ATP synthase subunit delta |
Schistosoma japonicum | Sjp_0082240 | ko:K02134 F-type H+-transporting ATPase delta chain, putative |
Schistosoma mansoni | Smp_082120 | ATP synthase delta chain mitochondrial |
Schmidtea mediterranea | mk4.000215.15 | ATP synthase subunit delta, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.6.4790 | ATP synthase, epsilon chain, putative |
Trypanosoma brucei | Tb927.6.4990 | mitochondrial ATP synthase delta chain |
Trypanosoma congolense | TcIL3000_6_4420 | ATP synthase, epsilon chain, putative |
Trypanosoma cruzi | TcCLB.506945.240 | ATP synthase, epsilon chain, putative |
Toxoplasma gondii | TGME49_226000 | ATP synthase, putative |
Theileria parva | TP02_0253 | ATP synthase F1, delta subunit, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0688 | ATP synthase F0F1 subunit epsilon |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu1333 | Mycobacterium tuberculosis | essential | nmpdr |
Tb927.6.4990 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.6.4990 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.6.4990 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.6.4990 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b3731 | Escherichia coli | non-essential | goodall |
CELE_F58F12.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F58F12.1 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_F58F12.1 | Caenorhabditis elegans | slow growth | wormbase |
YDL004W | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0901400 | Plasmodium berghei | Slow | plasmo |
TGME49_226000 this record | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Mycobacterium tuberculosis | Probable ATP synthase epsilon chain AtpC | Compounds | References |
4 literature references were collected for this gene.